Crohn’s Disease Therapeutics Market Growth Prospects and Outlook 2020-2028 | Johnson & Johnson Services Inc.; Pfizer Inc.; Allergan; AbbVie Inc.; Takeda Pharmaceutical Company Limited

Global Crohn’s Disease Therapeutics Market to Grow due to Increasing Prevalence of Inflammatory Bowel Disease

Higher prevalence of autoimmune disorders, a larger population base requiring effective therapies for diseases such as the Crohn’s disease, and increasing prevalence of inflammatory bowel syndrome are expected to drive the growth of the Global Crohn’s Disease Therapeutics Market. According to the National Inpatient Sample data, there was no significant change in the hospitalization rate from 2003 to 2013 when Crohn’s disease was the primary diagnosis. Hospitalization has increased considerably during this period from 44.2 to 59.7 per 100,000 population for secondary diagnosis. Rising development of novel biological agents and anti-cytokine agents with a different mechanism of action and the use of stem cells in treating several diseases are anticipated to drive the industry in the future.

Major companies functioning in the market are Johnson & Johnson Services Inc.; Pfizer Inc.; Allergan; AbbVie Inc.; Takeda Pharmaceutical Company Limited; Celgene Corporation; Perrigo Company PLC; Ferring B.V.; Salix Pharmaceuticals; Gilead Sciences Inc.; Genentech Inc.; and UCB India Private Limited.

Key Factors Impacting the Global Crohn’s Disease Therapeutics Market:

1. Based on the therapy type, the anti-inflammatory segment dominated the overall Crohn’s disease therapeutics market. Anti-inflammatories are the first line therapy drugs and are more targeted and effective.
2. Immune system suppressors have shown promising safety and efficacy.
3. Reduced rate of mortality, hospitalization, and surgery, coupled with improved patient quality of life, is expected to drive the market growth.

Available Exclusive Sample Copy of this Report at https://www.quincemarketinsights.com/request-sample-68372?utm_source=SK&utm_medium=OPENPR&utm_campaign=SK

Companies Seeking Product Approval and Collaborating to Form Strategic Business Partnerships

As per the recent trends, companies having various strategic collaborations and the growing support by government and healthcare agencies are expected to have a synergistic effect on market. Such developments lead to partnership and boost the market competition. Companies are also developing new products and seeking FDA Approvals.
1. 8 May 2020 – Takeda Pharmaceutical Company Limited announced receiving Marketing Authorization for Entyvio® (vedolizumab) by the European Commission.
2. December 14, 2019 – Takeda Pharmaceuticals U.S.A. and MiTest Health LLC announced partnership to launch outcome prediction tool for patients with Crohn’s disease (CD).

North America to Become the Largest Market due to Increasing R&D Activities
North America is holding the largest share of the global market due to the existence of an established R&D infrastructure, development of novel therapeutics, and rising prevalence of the disease.

China, Japan, India, South Korea, and Australia are among some of the key countries for the global market in the region. Other regions including the Middle East, Eastern Europe, and Rest of the World (South America and Africa) are estimated to be emerging markets during the forecast period.

This Global Crohn’s Disease Therapeutics Market Report Provides:
1. An overview of thorough analysis of the global marketand related technologies.
2. Study of the latest trends with precise annual growth rate estimates for compounds (CAGRs) and yearly valuations.
3. Identification of new market opportunities and targeted consumer marketing strategies for global market.
4. Demand for new applications with new technologies and breakdown
5. Wide-ranging company profiles of significant players in industry.

The report offered by our experts presents an exhaustive market study with have established segments such as application, product type, and region. Every segment of the market and its sub-segments are comprehensively and are based on their growth scenarios, market share, and CAGR. In each market segment, qualitative and quantitative information is offered with in-depth information for offering a complete market outlook.

Market Segmentation:

By Therapy Type:
• Anti-inflammatory
• Immune System Suppressors
• Antibiotics
• Surgical

By Region:
North America Crohn’s Disease Therapeutics Market
• North America, by Country
o US
o Canada
o Mexico
• North America, by Therapy Type

Europe Crohn’s Disease Therapeutics Market
• Europe, by Country
o Germany
o Russia
o UK
o France
o Italy
o Spain
o The Netherlands
o Rest of Europe
• Europe, by Therapy Type

Asia Pacific Crohn’s Disease Therapeutics Market
• Asia Pacific, by Country
o China
o India
o Japan
o South Korea
o Australia
o Indonesia
o Rest of Asia Pacific
• Asia Pacific, by Therapy Type

Middle East & Africa Crohn’s Disease Therapeutics Market
• Middle East & Africa, by Country
o UAE
o Saudi Arabia
o Qatar
o South Africa
o Rest of Middle East & Africa
• Middle East & Africa, by Therapy Type

South America Crohn’s Disease Therapeutics Market
• South America, by Country
o Brazil
o Argentina
o Colombia
o Rest of South America
• South America, by Therapy Type

Objectives of this report:
• To estimate market size for crohn’s disease therapeutics market on regional and global basis.
• To identify major segments in crohn’s disease therapeutics market and evaluate their market shares and demand.
• To provide a competitive scenario for the crohn’s disease therapeutics market with major developments observed by key companies in the historic years.
• To evaluate key factors governing the dynamics of crohn’s disease therapeutics market with their potential gravity during the forecast period.

Customization:
This study is customized to meet your specific requirements:
• By Segment
• By Sub-segment
• By Region/Country
• Product Specific Competitive Analysis

Contact:
Quince Market Insights
Office No- A109
Pune, Maharashtra 411028
Phone: APAC +91 706 672 4848 / US +1 208 405 2835 / UK +44 121 364 6144
Email: sales@quincemarketinsights.com
Web: www.quincemarketinsights.com

ABOUT US:
QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the world's most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

This release was published on openPR.